002390 信邦制药
已收盘 08-23 15:00:00
资讯
新帖
简况
信邦制药：基因测序方面，公司有下属机构可以提供分子病理诊断服务
证券之星 · 08-22
信邦制药：基因测序方面，公司有下属机构可以提供分子病理诊断服务
信邦制药（002390）8月20日主力资金净卖出19.15万元
证券之星 · 08-21
信邦制药（002390）8月20日主力资金净卖出19.15万元
豪门“赘婿”收获过亿融资前，“老丈人”减持信邦制药套现1.64亿
市场资讯 · 08-19
豪门“赘婿”收获过亿融资前，“老丈人”减持信邦制药套现1.64亿
减持竟为前夫借款？信邦制药董事长涉离婚风波
证券之星 · 08-19
减持竟为前夫借款？信邦制药董事长涉离婚风波
V观财报｜信邦制药回应90后董事长被前夫“声讨”：私事，不了解
中新经纬 · 08-19
V观财报｜信邦制药回应90后董事长被前夫“声讨”：私事，不了解
信邦制药：关于公司回购股份的后续安排，敬请您以公司在指定信息披露媒体上刊登的公告为准
证券之星 · 08-12
信邦制药：关于公司回购股份的后续安排，敬请您以公司在指定信息披露媒体上刊登的公告为准
信邦制药：公司旗下医院有淋巴细胞亚群、淋巴细胞活化、树突状细胞、细胞凋亡及白血病免疫分析等检测业务
证券之星 · 08-02
信邦制药：公司旗下医院有淋巴细胞亚群、淋巴细胞活化、树突状细胞、细胞凋亡及白血病免疫分析等检测业务
信邦制药：公司下属医院根据所在地区的政策规定，分别执行有DIP、DRG支付方式
证券之星 · 07-23
信邦制药：公司下属医院根据所在地区的政策规定，分别执行有DIP、DRG支付方式
信邦制药新提交1件商标注册申请
证券之星 · 07-23
信邦制药新提交1件商标注册申请
信邦制药：公司下属的医药流通公司暂未涉及您提及的业务
证券之星 · 07-18
信邦制药：公司下属的医药流通公司暂未涉及您提及的业务
信邦制药新提交1件商标注册申请
证券之星 · 07-13
信邦制药新提交1件商标注册申请
信邦制药：公司销售的医疗器械未涉及您提及的产品
证券之星 · 07-12
信邦制药：公司销售的医疗器械未涉及您提及的产品
信邦制药（002390）7月9日主力资金净买入275.98万元
证券之星 · 07-10
信邦制药（002390）7月9日主力资金净买入275.98万元
【A股股票回购一览：47家公司披露回购进展】Wind数据显示，7月10日，共47家公司发布股票回购相关公告。其中，2家公司股东提议回购公司股份，13家公司首次披露股票回购预案，3家公司回购方案获股东大会通过，12家公司披露股票回购实施进展，17家公司回购方案已实施完毕。
智通财经 · 07-10
【A股股票回购一览：47家公司披露回购进展】Wind数据显示，7月10日，共47家公司发布股票回购相关公告。其中，2家公司股东提议回购公司股份，13家公司首次披露股票回购预案，3家公司回购方案获股东大会通过，12家公司披露股票回购实施进展，17家公司回购方案已实施完毕。
信邦制药：关于公司的经营及业务情况，敬请您以公司在指定信息披露媒体上刊登的公告为准
证券之星 · 07-08
信邦制药：关于公司的经营及业务情况，敬请您以公司在指定信息披露媒体上刊登的公告为准
信邦制药：公司从道地药材基地采购的中药材主要用于自身生产中药饮片和中成药
证券之星 · 07-03
信邦制药：公司从道地药材基地采购的中药材主要用于自身生产中药饮片和中成药
信邦制药(002390.SZ)累计回购比例达2.35% 耗资1.94亿元
智通财经 · 07-02
信邦制药(002390.SZ)累计回购比例达2.35% 耗资1.94亿元
【信邦制药(002390.SZ)累计回购比例达2.35% 耗资1.94亿元】智通财经APP讯，信邦制药(002390.SZ)公告，截至2024年6月30日，公司累计回购股份数量为4565.
智通财经 · 07-02
【信邦制药(002390.SZ)累计回购比例达2.35% 耗资1.94亿元】智通财经APP讯，信邦制药(002390.SZ)公告，截至2024年6月30日，公司累计回购股份数量为4565.
信邦制药：公司《2024年半年度报告》将于2024年8月31日披露
证券之星 · 07-01
信邦制药：公司《2024年半年度报告》将于2024年8月31日披露
信邦制药(002390.SZ)已耗资1.75亿元回购2.07%股份
智通财经 · 06-06
信邦制药(002390.SZ)已耗资1.75亿元回购2.07%股份
公司概况
公司名称：
贵州信邦制药股份有限公司
所属行业：
医药制造业
上市日期：
2010-04-16
主营业务：
贵州信邦制药股份有限公司是一家从事医疗服务、医药流通和医药制造的公司。公司主要产品有银杏叶片、益心舒胶囊、六味安消胶囊、护肝宁片、脉血康胶囊等药品。公司已成为贵州省内医药流通的龙头企业，已具有区域性集团化企业的地缘优势，具有众多国内外知名上游供应商的省级独家代理权。
发行价格：
33.00
{"stockData":{"symbol":"002390","market":"SZ","secType":"STK","nameCN":"信邦制药","latestPrice":3.1,"timestamp":1724396586000,"preClose":3.14,"halted":0,"volume":12794382,"delay":0,"floatShares":1852000000,"shares":1944000000,"eps":0.1508,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.04,"latestTime":"08-23 15:00:00","open":3.13,"high":3.16,"low":3.08,"amount":39825300,"amplitude":0.0255,"askPrice":3.1,"askSize":1396,"bidPrice":3.09,"bidSize":5001,"shortable":0,"etf":0,"ttmEps":0.1508,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"adjPreClose":3.14,"symbolType":"stock","openAndCloseTimeList":[[1724376600000,1724383800000],[1724389200000,1724396400000]],"highLimit":3.45,"lowLimit":2.83,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1943851868,"pbRate":0.89,"roa":"--","roe":"0.86%","epsLYR":0.15,"committee":0.164682,"marketValue":6026000000,"floatMarketCap":5740000000,"peRate":20.557029,"changeRate":-0.0127,"turnoverRate":0.0069,"status":1},"requestUrl":"/m/hq/s/002390/wiki","defaultTab":"wiki","newsList":[{"id":"2461393536","title":"信邦制药：基因测序方面，公司有下属机构可以提供分子病理诊断服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2461393536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461393536?lang=zh_cn&edition=full","pubTime":"2024-08-22 17:15","pubTimestamp":1724318133,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药08月22日在投资者关系平台上答复投资者关心的问题。目前公司暂未开展您提及的其他业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082200030934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0056","BK0146","002390","BK0004","BK0239","BK0096","BK0028"],"gpt_icon":0},{"id":"2461986843","title":"信邦制药（002390）8月20日主力资金净卖出19.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461986843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461986843?lang=zh_cn&edition=full","pubTime":"2024-08-21 09:23","pubTimestamp":1724203431,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月20日收盘，信邦制药报收于3.23元，下跌3.58%，换手率0.86%，成交量15.96万手，成交额5208.81万元。近5日资金流向一览见下表：信邦制药融资融券信息显示，融资方面，当日融资买入451.63万元，融资偿还222.09万元，融资净买入229.54万元。信邦制药主营业务：医疗服务、医药流通及医药工业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082100009992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0239","BK0004","BK0028","002390","BK0096","BK0114","BK0056"],"gpt_icon":0},{"id":"2460260035","title":"豪门“赘婿”收获过亿融资前，“老丈人”减持信邦制药套现1.64亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2460260035","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460260035?lang=zh_cn&edition=full","pubTime":"2024-08-19 20:23","pubTimestamp":1724070180,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！截至2023年5月26日，刘光耀的抖音账号仅有1.6万粉丝。 巧合的是，在“bosie伯喜”收获这笔融资之前，信邦制药就发布了实控人之一减持股份的预披露公告，安吉父亲安怀略计划6个月内以集中竞价方","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-08-19/doc-incketke9488768.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-08-19/doc-incketke9488768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002390","BK0114","BK0239","BK0056","BK0096","BK0146","BK0004","BK0028"],"gpt_icon":0},{"id":"2460774461","title":"减持竟为前夫借款？信邦制药董事长涉离婚风波","url":"https://stock-news.laohu8.com/highlight/detail?id=2460774461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460774461?lang=zh_cn&edition=full","pubTime":"2024-08-19 13:09","pubTimestamp":1724044183,"startTime":"0","endTime":"0","summary":"近日，A股上市公司信邦制药董事长安吉与前夫、服饰品牌bosie(伯喜)创始人刘光耀因离婚风波引发了大家的关注。随后，在2023年1月，两人决定进一步发展关系，举行了订婚仪式。到了今年3月，两人经过深思熟虑后，决定结束这段婚姻关系，选择了离婚。《借款协议》显示，甲方为信邦制药前董事长、安吉之父安怀略，乙方为杭州伯喜服饰有限公司。协议显示，2023年8月14日至2024年8月14日期间，伯喜服饰向安怀略借款1000万元，用于企业日常经营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024081900012122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","BK0004","BK0239","002390","BK0056","BK0114","BK0146"],"gpt_icon":0},{"id":"2460773132","title":"V观财报｜信邦制药回应90后董事长被前夫“声讨”：私事，不了解","url":"https://stock-news.laohu8.com/highlight/detail?id=2460773132","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460773132?lang=zh_cn&edition=full","pubTime":"2024-08-19 11:12","pubTimestamp":1724037127,"startTime":"0","endTime":"0","summary":"近日，信邦制药董事长安吉前夫发布题为《致信邦集团董事长安吉女士书：是可忍，孰...","market":"sh","thumbnail":"http://www.jwview.com/jingwei/08-19/U789P902T1D604350F10DT20240819111207.jpg","type":0,"news_type":0,"thumbnails":["http://www.jwview.com/jingwei/08-19/U789P902T1D604350F10DT20240819111207.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.jwview.com/jingwei/html/08-19/604350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zxjw_stock","symbols":["002390"],"gpt_icon":0},{"id":"2458670676","title":"信邦制药：关于公司回购股份的后续安排，敬请您以公司在指定信息披露媒体上刊登的公告为准","url":"https://stock-news.laohu8.com/highlight/detail?id=2458670676","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458670676?lang=zh_cn&edition=full","pubTime":"2024-08-12 18:06","pubTimestamp":1723457190,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药08月12日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200024621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0004","BK0096","BK0114","BK0146","002390","BK0056","BK0239","BK0028"],"gpt_icon":0},{"id":"2456479794","title":"信邦制药：公司旗下医院有淋巴细胞亚群、淋巴细胞活化、树突状细胞、细胞凋亡及白血病免疫分析等检测业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2456479794","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456479794?lang=zh_cn&edition=full","pubTime":"2024-08-02 17:06","pubTimestamp":1722589566,"startTime":"0","endTime":"0","summary":"信邦制药董秘：您好，公司已在全国建立道地药材基地117个，面积达24.8万亩。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080200035333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","002390","BK0239","BK0028","BK0114","BK0056","BK0004","BK0096"],"gpt_icon":0},{"id":"2453081388","title":"信邦制药：公司下属医院根据所在地区的政策规定，分别执行有DIP、DRG支付方式","url":"https://stock-news.laohu8.com/highlight/detail?id=2453081388","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453081388?lang=zh_cn&edition=full","pubTime":"2024-07-23 18:04","pubTimestamp":1721729082,"startTime":"0","endTime":"0","summary":"有个安全区域同时可以给病人看病信邦制药董秘：您好，首先感谢您对公司的建议。自家技术肯定没有吧信邦制药董秘：您好，公司下属医院根据所在地区的政策规定，分别执行有DIP、DRG支付方式。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300034785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0056","BK0146","002390","BK0004","BK0239","BK0096","BK0028"],"gpt_icon":0},{"id":"2453708876","title":"信邦制药新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2453708876","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453708876?lang=zh_cn&edition=full","pubTime":"2024-07-23 14:14","pubTimestamp":1721715287,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日贵州信邦制药股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来贵州信邦制药股份有限公司新申请注册商标8件，截止目前公司共持有注册商标152件，另有12件商标尚在注册申请中。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300022185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","BK0004","BK0239","002390","BK0056","BK0114","BK0146"],"gpt_icon":0},{"id":"2452358170","title":"信邦制药：公司下属的医药流通公司暂未涉及您提及的业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2452358170","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452358170?lang=zh_cn&edition=full","pubTime":"2024-07-18 17:04","pubTimestamp":1721293465,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药(002390)07月18日在投资者关系平台上答复投资者关心的问题。投资者：公司旗下医药流通是否要开展无人驾驶配送呢？信邦制药董秘：您好，公司下属的医药流通公司暂未涉及您提及的业务。感谢您对公司的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071800036444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1574","09939","002390","BK0239","BK0028","BK0004","BK0056","BK0146","BK0096","BK1515","BK1161","BK0114"],"gpt_icon":0},{"id":"2451151899","title":"信邦制药新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2451151899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451151899?lang=zh_cn&edition=full","pubTime":"2024-07-13 13:01","pubTimestamp":1720846867,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日贵州信邦制药股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来贵州信邦制药股份有限公司新申请注册商标1件，截止目前公司共持有注册商标152件，另有5件商标尚在注册申请中。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071300013502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0146","BK0028","BK0239","BK0004","BK0114","002390","BK0056"],"gpt_icon":0},{"id":"2450658453","title":"信邦制药：公司销售的医疗器械未涉及您提及的产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2450658453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450658453?lang=zh_cn&edition=full","pubTime":"2024-07-12 20:04","pubTimestamp":1720785892,"startTime":"0","endTime":"0","summary":"信邦制药董秘：您好，在中成药方面，公司严格按照《药品生产质量管理规范》的要求，制定了完整的质量保证体系，确保药品的质量安全。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200047335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0004","BK0096","09996","BK1222","BK0239","BK0146","BK0056","BK0114","BK1574","BK1583","BK0028","002390","BK1100","09997","159883"],"gpt_icon":0},{"id":"2450167886","title":"信邦制药（002390）7月9日主力资金净买入275.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450167886","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450167886?lang=zh_cn&edition=full","pubTime":"2024-07-10 09:22","pubTimestamp":1720574525,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月9日收盘，信邦制药报收于3.29元，下跌1.2%，换手率0.99%，成交量18.13万手，成交额5950.01万元。近5日资金流向一览见下表：信邦制药融资融券信息显示，融资方面，当日融资买入1027.27万元，融资偿还363.36万元，融资净买入663.91万元。信邦制药主营业务：医疗服务、医药流通及医药工业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000015469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0028","BK0114","BK0239","BK0004","002390","BK0096","BK0056"],"gpt_icon":0},{"id":"2450021070","title":"【A股股票回购一览：47家公司披露回购进展】Wind数据显示，7月10日，共47家公司发布股票回购相关公告。其中，2家公司股东提议回购公司股份，13家公司首次披露股票回购预案，3家公司回购方案获股东大会通过，12家公司披露股票回购实施进展，17家公司回购方案已实施完毕。","url":"https://stock-news.laohu8.com/highlight/detail?id=2450021070","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450021070?lang=zh_cn&edition=full","pubTime":"2024-07-10 07:32","pubTimestamp":1720567962,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0226","LU0821914370.USD","002390","300379","LU1064131003.USD","002215","399300","LU1064130708.USD","BK0043","600887","BK0096","BK0027","BK0004","BK0086","IE00B5MMRT66.SGD","BK0231","LU0405327494.USD","LU1781817850.SGD","159982","BK0224","BK0093","002150","BK0188","603558","BK0077","BK0012","BK0196","LU0862451753.SGD","BK0229","BK0195","BK0174","BK0185","BK0239","BK0183","002557","600507","BK0238","IE00B543WZ88.USD","BK0048","LU2148510915.USD","002705","300820","LU1048596156.SGD","300737","SG9999002828.SGD","BK0030","BK0056","BK0132","603609","BK0028"],"gpt_icon":0},{"id":"2449377571","title":"信邦制药：关于公司的经营及业务情况，敬请您以公司在指定信息披露媒体上刊登的公告为准","url":"https://stock-news.laohu8.com/highlight/detail?id=2449377571","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449377571?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:02","pubTimestamp":1720436576,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药07月08日在投资者关系平台上答复投资者关心的问题。感谢您对公司的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800025920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0056","002390","BK0114","BK0096","BK0239","BK0004","BK0146"],"gpt_icon":0},{"id":"2448101560","title":"信邦制药：公司从道地药材基地采购的中药材主要用于自身生产中药饮片和中成药","url":"https://stock-news.laohu8.com/highlight/detail?id=2448101560","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448101560?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:01","pubTimestamp":1720008082,"startTime":"0","endTime":"0","summary":"公司已建立常用中药材战略储备机制，对冲中药材市场波动风险，可以有效降低中药材价格异动对公司经营的影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070300041466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0004","BK0096","BK0114","BK0146","002390","BK0056","BK0239","BK0028"],"gpt_icon":0},{"id":"2448844841","title":"信邦制药(002390.SZ)累计回购比例达2.35% 耗资1.94亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448844841","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448844841?lang=zh_cn&edition=full","pubTime":"2024-07-02 16:17","pubTimestamp":1719908265,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信邦制药(002390.SZ)公告，截至2024年6月30日，公司累计回购股份数量为4565.9万股，占公司总股本的2.35%，最高成交价为4.87元/股，最低成交价为3.29元/股，成交总金额为1.94亿元(不含交易费用)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","BK0056","BK0146","BK0004","BK0114","002390","BK0239","BK0028"],"gpt_icon":0},{"id":"2448184405","title":"【信邦制药(002390.SZ)累计回购比例达2.35% 耗资1.94亿元】智通财经APP讯，信邦制药(002390.SZ)公告，截至2024年6月30日，公司累计回购股份数量为4565.","url":"https://stock-news.laohu8.com/highlight/detail?id=2448184405","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448184405?lang=zh_cn&edition=full","pubTime":"2024-07-02 16:17","pubTimestamp":1719908265,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0146","BK0239","BK0004","BK0028","002390","BK0096","BK0114","BK0056"],"gpt_icon":0},{"id":"2448969483","title":"信邦制药：公司《2024年半年度报告》将于2024年8月31日披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2448969483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448969483?lang=zh_cn&edition=full","pubTime":"2024-07-01 17:06","pubTimestamp":1719824772,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药07月01日在投资者关系平台上答复投资者关心的问题。投资者：半年报何时披露，如果有利好，不要拖着，没有也早放出来信邦制药董秘：您好，公司《2024年半年度报告》将于2024年8月31日披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070100022277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0096","BK0028","BK0114","BK0146","BK0056","002390","BK0004"],"gpt_icon":0},{"id":"2441924557","title":"信邦制药(002390.SZ)已耗资1.75亿元回购2.07%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2441924557","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441924557?lang=zh_cn&edition=full","pubTime":"2024-06-06 18:50","pubTimestamp":1717671049,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信邦制药(002390.SZ)发布公告，截至2024年6月6日，公司累计回购股份数量为4020.61万股，占公司总股本的2.07%，最高成交价为4.87元/股，最低成交价为3.31元/股，成交总金额为1.75亿元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1132216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002390","BK0056","BK0146","BK0096","BK0004","BK0239","BK0114","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-04-16","address":"贵州省黔南布依族苗族自治州罗甸县龙坪镇信邦大道48号","stockEarnings":[{"period":"1week","weight":-0.0855},{"period":"1month","weight":-0.0159},{"period":"3month","weight":-0.1599},{"period":"6month","weight":-0.201},{"period":"1year","weight":-0.2846},{"period":"ytd","weight":-0.2909}],"companyName":"贵州信邦制药股份有限公司","boardCode":"AI0027","perCapita":"25326股","boardName":"医药制造业","registeredCapital":"194385万元","compareEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0164},{"period":"3month","weight":-0.0759},{"period":"6month","weight":-0.0501},{"period":"1year","weight":-0.0739},{"period":"ytd","weight":-0.0405}],"survey":" 贵州信邦制药股份有限公司是一家从事医疗服务、医药流通和医药制造的公司。公司主要产品有银杏叶片、益心舒胶囊、六味安消胶囊、护肝宁片、脉血康胶囊等药品。公司已成为贵州省内医药流通的龙头企业，已具有区域性集团化企业的地缘优势，具有众多国内外知名上游供应商的省级独家代理权。","serverTime":1724624344658,"listedPrice":33,"stockholders":"73112人(较上一季度增加0.05%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"信邦制药(002390)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供信邦制药(002390)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"信邦制药,002390,信邦制药股票,信邦制药股票老虎,信邦制药股票老虎国际,信邦制药行情,信邦制药股票行情,信邦制药股价,信邦制药股市,信邦制药股票价格,信邦制药股票交易,信邦制药股票购买,信邦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"信邦制药(002390)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供信邦制药(002390)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}